These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9129044)

  • 1. Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sézary syndrome.
    Thangavelu M; Finn WG; Yelavarthi KK; Roenigk HH; Samuelson E; Peterson L; Kuzel TM; Rosen ST
    Blood; 1997 May; 89(9):3371-7. PubMed ID: 9129044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicolor fluorescence in situ hybridization (SKY) in mycosis fungoides and Sézary syndrome: search for recurrent chromosome abnormalities.
    Batista DA; Vonderheid EC; Hawkins A; Morsberger L; Long P; Murphy KM; Griffin CA
    Genes Chromosomes Cancer; 2006 Apr; 45(4):383-91. PubMed ID: 16382449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sézary syndrome and mycosis fungoides.
    Mao X; Lillington D; Scarisbrick JJ; Mitchell T; Czepulkowski B; Russell-Jones R; Young B; Whittaker SJ
    Br J Dermatol; 2002 Sep; 147(3):464-75. PubMed ID: 12207585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE).
    Wood GS; Tung RM; Haeffner AC; Crooks CF; Liao S; Orozco R; Veelken H; Kadin ME; Koh H; Heald P
    J Invest Dermatol; 1994 Jul; 103(1):34-41. PubMed ID: 8027579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large cell transformation of Sézary syndrome. A conventional and molecular cytogenetic study.
    So CC; Wong KF; Siu LL; Kwong YL
    Am J Clin Pathol; 2000 Jun; 113(6):792-7. PubMed ID: 10874879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Banding studies of chromosomes in a patient with mycosis fungoides.
    Fukuhara S; Rowley JD; Variakojis D
    Cancer; 1978 Nov; 42(5):2262-8. PubMed ID: 719606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis.
    Diamandidou E; Colome-Grimmer M; Fayad L; Duvic M; Kurzrock R
    Blood; 1998 Aug; 92(4):1150-9. PubMed ID: 9694702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome aberrations, spontaneous SCE, and growth kinetics in PHA-stimulated lymphocytes of five cases with Sézary syndrome.
    Limon J; Nedoszytko B; Brozek I; Hellmann A; Zajaczek S; Lubiński J; Mrózek K
    Cancer Genet Cytogenet; 1995 Aug; 83(1):75-81. PubMed ID: 7656210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Histological Characteristics of Mycosis Fungoides and Sézary Syndrome: A Retrospective, Single-centre Study of 43 Patients from Eastern Denmark.
    Nielsen PR; Eriksen JO; Wehkamp U; Lindahl LM; Gniadecki R; Fogh H; Fabricius S; Bzorek M; Ødum N; Gjerdrum LM
    Acta Derm Venereol; 2019 Dec; 99(13):1231-1236. PubMed ID: 31620804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic studies of Sézary cells.
    Berger R; Bernheim A
    Cancer Genet Cytogenet; 1987 Jul; 27(1):79-87. PubMed ID: 3581043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
    Agar NS; Wedgeworth E; Crichton S; Mitchell TJ; Cox M; Ferreira S; Robson A; Calonje E; Stefanato CM; Wain EM; Wilkins B; Fields PA; Dean A; Webb K; Scarisbrick J; Morris S; Whittaker SJ
    J Clin Oncol; 2010 Nov; 28(31):4730-9. PubMed ID: 20855822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model.
    Scarisbrick JJ; Prince HM; Vermeer MH; Quaglino P; Horwitz S; Porcu P; Stadler R; Wood GS; Beylot-Barry M; Pham-Ledard A; Foss F; Girardi M; Bagot M; Michel L; Battistella M; Guitart J; Kuzel TM; Martinez-Escala ME; Estrach T; Papadavid E; Antoniou C; Rigopoulos D; Nikolaou V; Sugaya M; Miyagaki T; Gniadecki R; Sanches JA; Cury-Martins J; Miyashiro D; Servitje O; Muniesa C; Berti E; Onida F; Corti L; Hodak E; Amitay-Laish I; Ortiz-Romero PL; Rodríguez-Peralto JL; Knobler R; Porkert S; Bauer W; Pimpinelli N; Grandi V; Cowan R; Rook A; Kim E; Pileri A; Patrizi A; Pujol RM; Wong H; Tyler K; Stranzenbach R; Querfeld C; Fava P; Maule M; Willemze R; Evison F; Morris S; Twigger R; Talpur R; Kim J; Ognibene G; Li S; Tavallaee M; Hoppe RT; Duvic M; Whittaker SJ; Kim YH
    J Clin Oncol; 2015 Nov; 33(32):3766-73. PubMed ID: 26438120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelotyping in mycosis fungoides and Sézary syndrome: common regions of allelic loss identified on 9p, 10q, and 17p.
    Scarisbrick JJ; Woolford AJ; Russell-Jones R; Whittaker SJ
    J Invest Dermatol; 2001 Sep; 117(3):663-70. PubMed ID: 11564174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers.
    Hughes CF; Newland K; McCormack C; Lade S; Prince HM
    Australas J Dermatol; 2016 Aug; 57(3):182-91. PubMed ID: 25988337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome studies in mycosis fungoides.
    van Vloten WA; Pet EA; Geraedts JP
    Br J Dermatol; 1980 May; 102(5):507-13. PubMed ID: 7387897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis.
    Vural S; Akay BN; Botsalı A; Atilla E; Parlak N; Okçu Heper A; Şanlı H
    Turk J Haematol; 2018 Mar; 35(1):35-41. PubMed ID: 28533196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides.
    Molina A; Zain J; Arber DA; Angelopolou M; O'Donnell M; Murata-Collins J; Forman SJ; Nademanee A
    J Clin Oncol; 2005 Sep; 23(25):6163-71. PubMed ID: 16135483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycosis fungoides and Sézary syndrome.
    Espinet B; Salgado R
    Methods Mol Biol; 2013; 973():175-88. PubMed ID: 23412790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic abnormalities in patients with cutaneous T-cell lymphomas.
    Whang-Peng J; Bunn P; Knutsen T; Schechter GP; Gazdar AF; Matthews MJ; Minna JD
    Cancer Treat Rep; 1979 Apr; 63(4):575-80. PubMed ID: 312695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.